drug quantitation
was performed using LCM liquid chromatography with tandem mass spectrometry
quantitation (LC-MS/MS) as previously described.41 (link) Briefly, 3 × 106 μm2 regions
of mimetic, caseum, and normal lung were dissected and collected in
polymerase chain reaction (PCR) tubes for a liquid–liquid extraction
and LC-MS/MS quantitation. LC-MS/MS analysis was performed on a Sciex
QTRAP 6500+ triple-quadrupole mass spectrometer coupled to a Shimadzu
Nexera X2 UHPLC system. Chromatographic separation was performed on
an Agilent Zorbax SB-C8 column (2.1 × 30 mm; particle size, 3.5
μm) using a reverse-phase gradient elution of 0.1% formic acid
(FA) in Milli-Q water (mobile phase A) and 0.1% FA in acetonitrile
(mobile phase B) for Rifampicin, rifapentine, rifabutin and pretomanid.
For Doxycycline and Kanamycin, 0.1% heptafluorobutyric acid (HFBA)
was added to each mobile phase. Multiple-reaction monitoring (MRM)
of precursor/fragment transitions in electrospray positive-ionization
mode was used to quantify the analytes. Data processing was performed
using Analyst software (ver. 1.7.1; Applied Biosystems Sciex). Technical
triplicates (n = 3) were quantified for each drug.